The University Of Texas Health Science Center At San Antonio

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Quantifying Hepatic Mitochondrial Fluxes in Humans

Phase 4

Recruiting

Conditions: Non-Alcoholic Fatty Liver Disease
Type 2 Diabetes
Mitochondrial Metabolism Disorders

Interventions: Other: Placebo
Drug: Pioglitazone

First Posted Date: 2022-03-31

Last Posted Date: 2024-08-30

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 60

Registration Number: NCT05305287

Locations: 🇺🇸
Texas Diabetes Institute - University Health System, San Antonio, Texas, United States
🇺🇸
University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

Wellness App for Sleep Disturbance in Hematological Cancer Patients

Not Applicable

Recruiting

Conditions: Fatigue
Cancer
Inflammation
Sleep Disturbance
Anxiety
Depression

Interventions: Behavioral: Wellness app intervention #1
Behavioral: Wellness app intervention #2

First Posted Date: 2022-03-24

Last Posted Date: 2024-03-26

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 276

Registration Number: NCT05294991

Locations: 🇺🇸
Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States
🇺🇸
Mays Cancer Center at The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
🇺🇸
Arizona State University, Phoenix, Arizona, United States

Use of Aromatherapy in Conjunction With Physical/Occupational Therapy in an Acute Care Setting

Phase 1

Conditions: Nausea
Suffering, Physical

Interventions: Drug: Lavender Oil
Other: Placebo
Drug: Peppermint oil
Drug: Mandarin Oil

First Posted Date: 2022-03-16

Last Posted Date: 2024-07-03

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 200

Registration Number: NCT05282706

Locations: 🇺🇸
Bianca Gonzales, San Antonio, Texas, United States

Couple's Retreats for Posttraumatic Stress Disorder

Not Applicable

Terminated

Conditions: Posttraumatic Stress Disorder

Interventions: Behavioral: Accelerated, Intensive, Multi-Couple Cognitive Behavioral Couples Therapy

First Posted Date: 2022-03-10

Last Posted Date: 2023-07-12

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 20

Registration Number: NCT05274061

Locations: 🇺🇸
University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

Vertebral Marrow Attention Trial (VMAT)

Not Applicable

Completed

Conditions: Lung Cancer

Interventions: Other: Evidence-based radiation dose limitation to the vertebral bone marrow

First Posted Date: 2022-02-21

Last Posted Date: 2024-10-30

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 12

Registration Number: NCT05248256

Locations: 🇺🇸
Vanderbilt-Ingram Service for Timely Access, Nashville, Tennessee, United States
🇺🇸
Mays Cancer Center, UT Health San Antonio, San Antonio, Texas, United States

Dose Escalation Trial of Bexmarilimab (FP-1305) Plus Pembrolizumab in Non-Small Cell Lung Cancer

Phase 1

Withdrawn

Conditions: Non-small Cell Lung Cancer

Interventions: Drug: bexmarilimab (FP-1305)
Drug: Pembrolizumab

First Posted Date: 2021-12-28

Last Posted Date: 2023-07-20

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Registration Number: NCT05171062

Locations: 🇺🇸
Mays Cancer Center, UT Health San Antonio, San Antonio, Texas, United States

Adjuvant High-intensity Interval Training During Chemotherapy in Metastatic Prostate Cancer Patients

Not Applicable

Withdrawn

Conditions: Castrate Resistant Prostate Cancer
Metastatic Prostate Cancer
Prostate Cancer Metastatic
Metastatic Prostate Adenocarcinoma

Interventions: Other: High Intensity Interval Training

First Posted Date: 2021-12-14

Last Posted Date: 2024-02-26

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Registration Number: NCT05156372

Locations: 🇺🇸
UT Health San Antonio, San Antonio, Texas, United States

Enhancing Prolonged Exposure With Cannabidiol to Treat Posttraumatic Stress Disorder

Phase 1

Completed

Conditions: Posttraumatic Stress Disorder
Stress Disorders, Post-Traumatic

Interventions: Drug: Cannabidiol (CBD) oral solution
Drug: Placebo
Behavioral: Massed Prolonged Exposure (mPE)

First Posted Date: 2021-11-24

Last Posted Date: 2024-10-10

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 21

Registration Number: NCT05132699

Locations: 🇺🇸
University of Texas Health Science Center at San Antonio - STRONG STAR Northwest Center, San Antonio, Texas, United States

Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM

Early Phase 1

Completed

Conditions: Glucose Tolerance Impaired
Insulin Sensitivity
Type 2 Diabetes

Interventions: Drug: REMD-477
Drug: Placebo Subcutaneous injection

First Posted Date: 2021-10-26

Last Posted Date: 2024-08-09

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 4

Registration Number: NCT05093517

Locations: 🇺🇸
Texas Diabetes Institute, San Antonio, Texas, United States

Enhancing Resiliency and Optimizing Readiness in Military Personnel

Not Applicable

Recruiting

Conditions: Stress, Physiological
Resilience, Psychological

Interventions: Behavioral: Psychological Flexibility Training (PFT)

First Posted Date: 2021-10-26

Last Posted Date: 2024-11-20

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 600

Registration Number: NCT05094115

Locations: 🇺🇸
Fort Hood, Killeen, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy